Skip to main content
Clinical Trials/ISRCTN15940781
ISRCTN15940781
Active, not recruiting
未知

Biomarkers for detection of dysplastic Barrett’s oesophagus in retrospective capsule sponge samples

Cyted Ltd0 sites150 target enrollmentJuly 23, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
Oesophageal dysplasia
Sponsor
Cyted Ltd
Enrollment
150
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 23, 2024
End Date
September 30, 2027
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Cyted Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\. 18 years old or over
  • 2\. Male or Female
  • 3\. Previously diagnosed with Barrett’s oesophagus
  • 4\. Capsule sponge test performed after 1 June 2021 with a positive p53 and/or positive atypia biomarker result
  • 5\. Endoscopic biopsy with pathology performed subsequent to capsule sponge
  • 1\. 18 years old or over
  • 2\. Male or Female
  • 3\. Previously diagnosed with Barrett’s oesophagus
  • 4\. Capsule sponge test performed after 1 January 2022 with a negative p53 and negative atypia biomarker result
  • 5\. Endoscopic biopsy with pathology performed subsequent to capsule sponge with non\-dysplastic pathology observed

Exclusion Criteria

  • 1\. Under 18 years old
  • 2\. Barrett’s diagnosis unconfirmed
  • 3\. Capsule sponge biomarker test missing p53 and atypia results
  • 4\. Missing endoscopic pathology results
  • 5\. Patient deceased

Outcomes

Primary Outcomes

Not specified

Similar Trials